Tag: Human Papillomavirus (HPV)
Approval of First HPV Test for Use With SurePath Preservative Fluid
For cervical cells obtained for Pap test, collected in SurePath Preservative Fluid
ASCO Presents Guidelines for Increasing HPV Vaccine Uptake
Oncologists should raise awareness of HPV-related cancers and role of vaccinations
HIV-Seropositive CIN3+ Patients Have Lower HPV16 Prevalence
HIV-seropositive women have lower HPV-16, higher non-alpha-9 oncHPV prevalence
Most HPV+ OPSCC Recurrence, Toxicity Events Occur Early
Two-thirds of disease recurrence and late toxicity events occur within six months
ACIP Approves 2016 Adult Immunization Schedule
Changes to schedule for HPV, pneumococcal, and meningococcal vaccines
Research Suggests Broader Role for HPV in HNSCC Etiology
HPV-16 and other HPVs, including γ11- and γ12-HPV species and β1-HPV-5 type, all implicated
Geographic Variation in HPV Oropharyngeal Cancer Prevalence
HPV-positive oropharyngeal cancer prevalence varies between Western Europe and Eastern Europe, Asia
Geographic Factors Impact HPV Vaccine Initiation in Teen Girls
Higher initiation among girls in high- vs. low-poverty areas, communities with mainly Hispanic, mixed race
β-Genus Human Papillomavirus Poses Skin Cancer Risk
HPV subtypes 5, 8, 17, 20, and 38 tied to significant increased risk
Not All PCPs Strongly Recommend HPV Vaccine
About 60 percent of pediatricians, family doctors recommend vaccine for 11- to 12-year-old girls
